drugset
drugset / Trial / NCT01302132

Mass Balance Study of ASP1941

NCT01302132 ↗

Phase 1 Completed 6 enrolled Astellas Pharma Inc
NaSingle-groupOpen-label

Summary

This study investigates the pharmacokinetics, in particular the routes and extent of metabolism and excretion, of ASP1941 after a single oral dose.

Timeline

Start
2008-05
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule — Oral

Indications

No indication recorded.